Andrew L. Pecora, MD

Articles

What Patients Don't Know Might Hurt Them

March 26th 2012

Complementary! Sounds good, how could it hurt? When applied in cancer therapy, however, what sounds good may not always be good for patients.

Where Are the Drugs?

February 24th 2012

In 2011, the FDA reported 232 cancer therapies to be in limited supply. As a result, many patients have had therapies delayed or discontinued, and in some cases, patients have been left without access to appropriate alternatives.

Taking Comfort

January 30th 2012

Much has been made of the difficulties companies, investigators, and patient advocates have in providing access to novel therapies.

The FDA Revokes

December 21st 2011

The FDA has broad authority to regulate food safety, as well as the safety, efficacy, and utilization of drugs and medical devices.

Not All Viruses Are the Same

December 5th 2011

A look at tweaking the corruptive influence of the virus information code to selectively corrupt cancer cells while sparing (normal) cells that do not have a specific cancer phenotype.

Cell or Sell: That Is the Question

September 23rd 2011

In vitro cell manipulation has unleashed the therapeutic potential of human cells.

Quality-of-Life Targeted Therapies

August 8th 2011

In the context of caring for cancer patients, all physicians and nurses trained in oncology receive education in quality-of-life issues; however, prolonging quantity of life remains our ultimate goal.

Genomic Chaos

July 22nd 2011

Oncologists need to prepare for a new era in which rapidly advancing genetic technology will change the way cancer is treated.

'Dark Energy' Within the Human Cell

June 14th 2011

Recently, significant attention has been focused on dark energy, despite our inability to directly detect it, because it represents 72% of everything in the universe

Leaving One "Haze" and Entering Another

May 20th 2011

The explosion of knowledge emanating from laboratories and clinics across the globe is steadily clearing the "haze" that shrouds the molecular basis of malignant cell transformation, growth, and spread